XBI
State Street SPDR S&P Biotech ETF
$131.66
-1.12
(-0.84%)
AUM
$8.30B
Expense Ratio
0.35%
NAV
$132.80
Holdings
151
Asset Class
Equity
Inception
01/31/2006
Provider
SPDR
Top Holdings
1
APLS
APELLIS PHARMACEUTICALS INC
1.82%
2
RVMD
REVOLUTION MEDICINES INC
1.79%
3
TVTX
TRAVERE THERAPEUTICS INC
1.75%
4
TGTX
TG THERAPEUTICS INC
1.62%
5
ALKS
ALKERMES PLC
1.54%
6
ARWR
ARROWHEAD PHARMACEUTICALS IN
1.50%
7
TWST
TWIST BIOSCIENCE CORP
1.45%
8
CELC
CELCUITY INC
1.43%
9
CYTK
CYTOKINETICS INC
1.42%
10
NBIX
NEUROCRINE BIOSCIENCES INC
1.39%
Fund Description
The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing